NORTHERN TRUST CORP - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 23 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$3,096,354
+17.0%
270,424
+5.0%
0.00%0.0%
Q2 2023$2,647,347
+76.8%
257,524
+32.8%
0.00%
Q1 2023$1,497,580
+6.4%
193,987
+1.3%
0.00%
Q4 2022$1,408,054
+57.1%
191,572
+53.9%
0.00%
Q3 2022$896,000
-16.3%
124,478
-1.0%
0.00%
Q2 2022$1,071,000
+17.4%
125,774
+23.7%
0.00%
Q1 2022$912,000
-37.7%
101,708
-3.7%
0.00%
Q4 2021$1,463,000
+27.9%
105,595
-1.5%
0.00%
Q3 2021$1,144,000
+11.9%
107,234
-5.6%
0.00%
Q2 2021$1,022,000
+384.4%
113,579
+470.4%
0.00%
Q1 2021$211,000
-15.3%
19,913
+0.6%
0.00%
Q4 2020$249,000
+91.5%
19,801
+34.4%
0.00%
Q3 2020$130,000
+348.3%
14,733
+44.6%
0.00%
Q1 2020$29,000
-25.6%
10,1880.0%0.00%
Q4 2019$39,000
-4.9%
10,188
-0.7%
0.00%
Q3 2019$41,000
-6.8%
10,260
-1.0%
0.00%
Q2 2019$44,000
-38.0%
10,3600.0%0.00%
Q1 2019$71,00010,3600.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q2 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders